AzTrials
AzTrials

Nutritional DisorderNCT04554082

Evaluation of Micronutrients in Obese Patients

An observational study of Nutritional Disorder, run by Alexandria University.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the study primarily was to investigate the value of zinc to copper ratio as possible biomarker of trace elements imbalance in morbidly obese subjects undergoing LSG. Secondly to correlate zinc to copper ratio with lipocalin 2 (Lcn2) with respect to Anthropometric measurements and other metabolic biomarkers. Read more about this study

Who is it for?
Ages 20 to 55 years
Conditions the study is for
Nutritional Disorder
What is being tested?
laparoscopic sleeve gastrectomy
Type of treatment
Surgery or procedure
How many people
107 participants
Where
No sites listed yet
Study dates
1 Jan 2015to 1 Apr 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 55 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: adult obese subjects with BMI above 40 both males and females presence of obesity comorbidities as hypertension, insulin resistance "type 2 DM" eligible for laporoscopic sleeve gatrectomy

Who may be able to join

  • micronutrient deficiency in morbid obese subjects Adults.
  • BMI above 40
  • presence of comorbidities as hypertenion, DM, dislipidemia

Who cannot join

  • all causes which might cause micronutrient deficiency as presence of gastroesophageal reflux
  • all causes which may cause increase obesity "BMI" as hormonal disturbance ; hypothyroidism or cushing, females receiving contraceptive pills

About this study

Official title: Impact of Zinc to Copper Ratio and Lipocalin 2 in Obese Patients Undergoing Sleeve Gastrectomy.

The aim of the study primarily was to investigate the value of zinc to copper ratio as possible biomarker of trace elements imbalance in morbidly obese subjects undergoing LSG.

Secondly to correlate zinc to copper ratio with lipocalin 2 (Lcn2) with respect to Anthropometric measurements and other metabolic biomarkers.

Prospective study will be carried out on 120 morbidly obese adult subjects with a body mass index (BMI) score above 40 along with presence of obesity-related comorbidity. Investigations will be measured preoperative and 9 months postoperative after performing Laparoscopic sleeve gastrectomy; for Body mass index (BMI) and waist circumference. As well as for complete blood count and biochemical biomarkers as fasting blood glucose, lipid profile, serum iron and ferritin. Serum Ceruloplasmin, Zn and Cu levels, followed by calculation of zinc to copper ratio. CRP, serum insulin, serum leptin and lipocalin-2 (Lcn2) will be determined.

Read the detailed description

CONSORT 2010 Flow Diagram

Materials and methods:

Recruitment Morbidly obese subjects attending clinic at Surgery department for laparoscopic sleeve gastrectomy Alexandria University Hospitals.

Pre-assignment Details adult morbidly obese subjects were included age above 20 years, BMI above 40 Suffering from comorbidities as hypertension, DM, dyslipidemia. Assigned participants were clinically evaluated for comorbidities as hypertension, DM, dyslipidemia.

As well as signs of nutritional deficiency as anemia, brittle nails.

Group Information one group of participants eligible for laparoscopic sleeve gastrectomy were assigned according to their will to participate in study.

Period of evaluation:

First visit: preoperative for clinical assessment of participants, determine BMI and waist circumference and withdrawal of serum blood sample Second visit: within one month after surgery to make sure that no complication occurred after surgery.

Third visit: nine months postoperative for revaluation of participants, determine BMI and waist circumference, and withdrawal of a serum blood sample

Number of participants at initiating the period of study. They were 120 morbidly obese subjects. Number of participants at the end of the period of study. They were 107 subjects, 13 obese subject withdraw from study as they didn't come during follow up period after 9 months.

Participants according Sex (69 females, and 38 male), with the mean age of 41.6±8.9 years. The mean preoperative BMI was 47.43±5.4 kg/m2. Then, they were evaluated 9 months after LSG.

Preoperative and Postoperative Clinical characteristics and metabolic variables in studied subjects.

Preoperative 9 months postoperative P Body weight (Kg) 129.7 ± 12.1 93.4 ±13.6 0.0013* BMI (kg/m2) 47.43±5.4 35.7±3.8 0.0052* Waist circumference (cm) 130.00 ± 4.68 91.82 ± 3.73 0.001* Systolic BP (mmHg) 146.0±17.0 132.0±11.0 0.001* Total cholesterol (mmol/L) 5.85 ± 0.41 4.64 ± 0.31 0.035* Triglycerides (mmol/L) 2.20 ± 0.23 1.92 ± 0.24 0.106 HDL cholesterol (mmol/L) 1.23 ± 0.19 1.39 ± 0.2 0.041* LDL cholesterol (mmol/L) 3.37 ± 0.23 2.97 ± 0.21 0.022* HOMA-IR 2.64 ± 1.3 1.44 ± 0.81 0.013* S. Leptin (ng/ml) 102.87 ± 49.16 33.47 ±12.76 0.0001* CRP (mg/L) 8.4±5.91 3.2±2.98 0.001* Lipocalin 2 (µg/L) 107.24±36.8 51.6±12.73 0.001* Albumin (g/dl) 4.05±0.21 3.91±0.29 0.113

*Statistically significant at (p≤0.05).

Outcome measures:

primarily was to investigate the value of zinc to copper ratio as possible biomarker of TE imbalance in morbidly obese subjects undergoing LSG.

For detection of presence of micronutrient deficiency in morbid obesity in form of zinc to copper ratio and re-evaluate it after loss of weight

Secondly to correlate it with lipocalin 2 (Lcn2) with respect to Anthropometric measurements and other metabolic markers prospectively.

As zinc to copper ratio is considered as biomarker of micronutrient status; therefore, correlate it with other biomarkers of inflammation (lipocalin 2) and other parameters as BMI, FBG to determine if micronutrient status improve after weight loss or not Time frame: 9 months.

Follow-up and outcome parameters:

All studied subjects will be followed up for early postoperative complications (within the first month) as Bleeding or Leak. Then they will be reviewed after 9 months postoperatively for assessment of anthropometric measurements, control of preoperative comorbidities, and manifestations of TE deficiencies (anemia, hair loss, teeth problems, edema. etc.).

Anthropometric parameters

Body mass index (BMI) and waist circumference will be measured preoperative and 9 months postoperative.

Biochemical parameters

Fasting blood samples will be collected from participants prior to surgery and nine months postoperative, after overnight fast and divided into two tubes; EDTA for complete blood count, the rest into plastic tubes and serum sample.

Serum glucose and Total cholesterol, HDL- cholesterol, LDL- cholesterol, and triglyceride, total protein and Albumin. Serum iron (Fe), and ferritin.

Serum insulin, Ceruloplasmin, Zn and Cu levels, CRP and lipocalin-2 (Lcn2) .

Statistical analysis

All data will be analyzed with Statistical Package for the Social Sciences version 20 software (SPSS, Inc., Chicago, IL). Results will be displayed as mean ± SD. Paired Student's t-test used to compare the data pre-operative and nine months postoperative. The chi-squared test used for category variables. Spearman correlation coefficient used to detect the correlation between different variables. Statistical correlations calculated by Pearson's correlation test. P < 0.05 is considered significant.

Being tested
laparoscopic sleeve gastrectomy
Keywords
obesity, zinc, copper, lipocalin 2
Medical subject headings
Nutrition Disorders, Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • laparoscopic sleeve gastrectomyProcedure or surgery

    bariatric surgery to loss weight

Study groups in NCT04554082
Study groupRoleWhat they receive
Preoperative Clinical characteristics and metabolic biomarkersBMI and biochemical parameters including trace elements in patients undergoing laparoscopic sleeve gastrectomy before surgery
Receives: Procedure: laparoscopic sleeve gastrectomy
9 months' Postoperative metabolic biomarkersBMI and biochemical parameters including trace elements in patients 9 months after laparoscopic sleeve gastrectomy
Receives: Procedure: laparoscopic sleeve gastrectomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evaluation of zinc to copper ratio as biomarker of micro-nutrient deficiency

    detect if there are micronutrient deficiency in morbid obesity in form of zinc to copper ratio and re-evaluate it after loss of weight

    Measured: nine months

Secondary outcomes (1)
  1. correlate zinc to copper ratio to lipocalin 2 and other metabolic biomarkers

    zinc to copper ratio is considered as biomarker of micronutrient status; therefore, it is correlated it with BMI, other biomarkers of inflammation (lipocalin 2) and other parameters as BMI, FBG to determine if micronutrient status improve after weight loss or not

    Measured: nine months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Sep 2020
  2. Study start1 Jan 2015
  3. Primary completion1 Jan 2020
  4. Study completion1 Apr 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
107 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04554082
Sponsor's protocol ID
0304707
Other IDs
00018699, 00012098
Status last verified
Sep 2020
First submitted
6 Sep 2020
Last updated
18 Sep 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Yerlikaya FH, Toker A, Aribas A. Serum trace elements in obese women with or without diabetes. Indian J Med Res. 2013 Feb;137(2):339-45.

    PubMed 23563378

Questions about this trial

What is this clinical trial studying?

An observational study of Nutritional Disorder, run by Alexandria University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evaluation of zinc to copper ratio as biomarker of micro-nutrient deficiency (time frame: nine months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04554082, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Sep 2020; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in